| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |